Startup profile · funding coverage
Authenticx funding, valuation and investors
Healthcare conversational intelligence — analyze customer call and interaction data at scale.
Keep track of Authenticx
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series B
$20M · January 2023
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$20M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series b · Indianapolis, IN
Investors in latest funding
Lead: Blue Heron Capital
Other: High Alpha , Elevate Ventures , Beringea , Allos Ventures
Overview
Authenticx is an Indianapolis platform that helps healthcare organizations analyze customer conversations (calls and related interactions) for insights, quality, and experience improvement. In January 2023 it announced a $20 million Series B led by Blue Heron Capital, with participation from Beringea, Indiana Next Level Fund/50 South Capital Advisors, High Alpha, Mutual Capital Partners, Signal Peak Ventures, Allos Ventures, Elevate Ventures, and M25. IBJ reported total funding around $28.8M since the 2018 launch. At announcement the company cited customers including five of the top 10 global pharmaceutical companies.
Why Authenticx is interesting
Indianapolis healthcare AI company that raised a $20M Series B (Jan 2023) led by Blue Heron Capital, with High Alpha and Elevate Ventures participating — listening layer for pharma and health call centers.
Product & use cases
Conversational intelligence software that mines healthcare customer interactions for themes, risk, and experience signals.
- Pharma patient-support call analytics
- Payer/provider contact-center quality programs
- Compliance and experience monitoring from voice data
Key facts
- Series B (Jan 2023): $20M led by Blue Heron Capital (PR Newswire)
- Participants included High Alpha and Elevate Ventures
- Cited five of top 10 global pharma as customers at raise
- Total funding ~$28.8M per IBJ at announcement
Funding history (newest first)
Series B
2023-01 $20M- Blue Heron Capital (lead)
- High Alpha (participant)
- Elevate Ventures (participant)
- Beringea (participant)
- Allos Ventures (participant)
Investors in our directory
Funds linked from Authenticx's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Healthcare-specific conversational intelligence with Indy GTM and Series B growth capital.
-
CallMiner / NICE incumbent
Enterprise conversation analytics.
-
Observe.AI adjacent
AI contact-center platforms.
-
Qualtrics XM adjacent
Broader experience management.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Authenticx's financing or category context.
FAQs about Authenticx
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.